Sullivan & Worcester advised Channel, Latham & Watkins advised Ligand, while Kelley Drye & Warren represented Murchinson on the deal. Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and...
Channel Therapeutics Corporation’s Merger With Pelthos Therapeutics
ELIQUENT Life Sciences’ Acquisition of Truliant Consulting
Ropes & Gray advised ELIQUENT Life Sciences and GHO Capital on the transaction, and Sullivan and Worcester advised Truliant Consulting. ELIQUENT Life Sciences (ELIQUENT) and GHO...
BiomX’s $12 Million Financing
Haynes and Boone served as legal counsel to BiomX, while Sullivan & Worcester served as legal counsel to Laidlaw on the transaction. BiomX Inc (NYSE American:...
Oxbridge Re Holdings Limited’s $3 Million Shares Offering and Private Placement
Sullivan & Worcester was placement agent’s counsel for Maxim Group LLC in the offering. Oxbridge Re Holdings Limited (Nasdaq: OXBR) announced its $3 million registered direct...
Plus Therapeutics’ $15 Million Private Placement
Sullivan & Worcester and Hogan Lovells US advised Plus Therapeutics, while Sichenzia Ross Ference Carmel represented D. Boral Capital on the offering. Plus Therapeutics, Inc. (Nasdaq:...
LogicMark’s $14.4 Million Public Offering
Sullivan & Worcester LLP served as special counsel for LogicMark in connection with the offering. LogicMark, Inc. (NASDAQ: LGMK), a provider of personal emergency response systems,...
Digital Ally’s $15 Million Common Stock Offering
Sullivan & Worcester acted as counsel to Digital Ally, while Kaufman & Canoles acted as counsel to Aegis Capital Corp. Digital Ally, Inc. (Nasdaq: DGLY) announced...
Palatin’s $4.7 Million Common Stock Offering
Thompson Hine advised Palatin Technologies, while Sullivan & Worcester advised the placement agents on the offering. Palatin Technologies, Inc. (NYSE: PTN) announced a $4.7 million registered...
Wearable Devices’ $2.5 Million Shares Offering
Sullivan & Worcester advised Wearable Devices Ltd. on the offering. Wearable Devices Ltd (Nasdaq: WLDS, WLDSW) completed its $2.5 million “best efforts” public offering of ordinary...
Cibus’ $22.6 Million Common Stock Offering
Jones Day acted as counsel for Cibus, while Sullivan & Worcester acted as counsel for A.G.P./Alliance Global Partners in the offering. Cibus, Inc. (Nasdaq: CBUS) announced...
SELLAS Life Sciences Group’s $25 Million Common Stock Offering
Sullivan & Worcester was placement agent’s counsel for A.G.P./Alliance Global Partners and Maxim Group LLC in connection with the offering. SELLAS Life Sciences Group, Inc. (Nasdaq:...
Stardust Power’s $5.75 Million Common Stock and Warrants Offering
Thompson Hine represented Stardust Power, Inc., while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Stardust Power Inc. (Nasdaq: SDST) completed its $5.75 million...